RedHill Biopharma (RDHL) EBITDA (2012 - 2023)
RedHill Biopharma (RDHL) posted quarterly EBITDA of $53.8 million for Q2 2023, up 486.88% year-over-year from $9.2 million in Q2 2022, and up 284.84% quarter-over-quarter from -$29.1 million in Q1 2023.
RedHill Biopharma (RDHL) EBITDA (2012 - 2023) Analysis & Trends
RedHill Biopharma (RDHL) has reported EBITDA for 12 consecutive years, with $53.8 million the latest figure, recorded in Q2 2023.
- In Q2 2023, EBITDA rose 486.88% year-over-year to $53.8 million; the TTM figure through Jun 2023 stood at -$44.0 million (up 55.32% YoY), while the FY2025 annual figure was -$7.9 million, down 22.66% from the prior year.
- EBITDA improved to $53.8 million in Q2 2023 per RDHL's latest filing, from -$29.1 million in the prior quarter.
- Across five years, EBITDA topped out at $53.8 million in Q2 2023 and bottomed at -$141.6 million in Q4 2021.
- Historically, EBITDA has averaged $421000.0 across 5 years, with a median of $12.4 million in 2019.
- Annual changes were most pronounced in 2021 — EBITDA plunged 818.34% — and 2023, when it jumped 486.88%.
- RedHill Biopharma's EBITDA stood at $11.8 million in 2019, then soared by 67.53% to $19.7 million in 2020, then slumped by 818.34% to -$141.6 million in 2021, then jumped by 46.5% to -$75.7 million in 2022, then soared by 170.97% to $53.8 million in 2023.
- Business Quant data shows RDHL's EBITDA at $53.8 million in Q2 2023, -$29.1 million in Q1 2023, and -$75.7 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 53.75 Mn |
| Mar 31, 2023 | -29.08 Mn |
| Dec 31, 2022 | -75.74 Mn |
| Sep 30, 2022 | 7.11 Mn |
| Jun 30, 2022 | 9.16 Mn |
| Mar 31, 2022 | 16.63 Mn |
| Dec 31, 2021 | -141.57 Mn |
| Sep 30, 2021 | 17.40 Mn |
| Jun 30, 2021 | 24.89 Mn |
| Mar 31, 2021 | 18.15 Mn |
| Dec 31, 2020 | 19.71 Mn |
| Sep 30, 2020 | 14.46 Mn |
| Jun 30, 2020 | 12.50 Mn |
| Mar 31, 2020 | 17.02 Mn |
| Dec 31, 2019 | 11.76 Mn |
| Sep 30, 2019 | 9.84 Mn |
| Jun 30, 2019 | 12.38 Mn |
| Mar 31, 2019 | 9.21 Mn |
| Dec 31, 2018 | 10.04 Mn |
| Sep 30, 2018 | 9.74 Mn |